Overview
Takeda Pharmaceutical of Osaka researches, develops, manufactures and markets pharmaceutical drugs through business divisions for gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, vaccines and neuroscience.[2] Forbes records sales of US$29.9bn, 1.1% below the prior-year figure, and profit of US$1.3bn, a margin of just over 4%.[2] It is the largest of the four Japanese companies in the ranking; Forbes records that Takeda Chobei founded it on 12 June 1781.[2] Its plasma-derived therapies division operates in the same field as CSL Behring, part of CSL, ranked twentieth. Market value is US$52.6bn.[2]
Takeda Pharmaceutical strengths and limitations
Strengths
- Largest Japanese pharmaceutical company by sales
- Broad presence in rare diseases
- Plasma business is hard to replicate
Limitations
- Sales fell 1.1%
- Profit margin about 4%
- Results translated from yen
Appears in
Takeda Pharmaceutical peers and competitors
Companies ranked in the same lists as Takeda Pharmaceutical.
Johnson & Johnson- Amgen
Daiichi Sankyo- Astellas Pharma
Viatris- Regeneron Pharmaceuticals
- CSL
Otsuka Holdings- Teva Pharmaceutical
Merck KGaA
Gilead Sciences
GSK plc
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.